Asset Manager

Updated:

Spexis Ltd

Spexis Ltd is a asset manager based in Allschwil, founded 2021; the Altss profile covers its classification, headquarters, registration, AUM band, and key...

Spexis Ltd

General information

Firm type

Asset Manager

Year founded

2021

Location

Region

Europe

Country

Switzerland

City

Allschwil

Corporate office

Allschwil, Switzerland

Principals

Jeff Wager

Co-Founder & CEO

Sector focus

BiotechPharmaceuticals

Frequently asked questions

Who makes investment and development decisions at Spexis?

Jeff Wager, MD, serves as Co-Founder & CEO and leads strategic and operational decisions. He has built over $2B in biotech market value through prior ventures (per firm website).

How does Spexis fund its drug development?

Spexis does not publicly disclose its funding model. The firm's origin came via a reverse merger of Enbiotix and Polyphor, and it likely relies on equity raises, partnerships, or grants typical for publicly-listed biotech companies.

What therapeutic areas does Spexis pursue?

Spexis targets macrocycle therapeutics for infectious disease and oncology. Its platform aims to drug historically undruggable protein targets using macrocycles — larger than small molecules but smaller than biologics.

Is Spexis a family office or a biotech operating company?

Spexis is a biotech operating company, not a family office. It develops its own drug candidates and may raise capital from institutional investors or partners.

What prior companies has Jeff Wager built?

Wager co-founded Grupo Biotoscana SL (IPO at $1B), Artisan Pharma (acquired by Asahi Kasei), and Enbiotix, among others. He also advised Zambon Group's €60M corporate venture fund (per firm website).

Where is Spexis headquartered?

Spexis operates from Allschwil, Switzerland.

Does Spexis have subsidiaries or affiliated entities?

The firm's website lists only the single entity 'Spexis Ltd.' No subsidiaries or parent structures are publicly disclosed.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Allschwil Asset Manager profiles